Search research articles
Contact Us
Filters
Showing results (31-40 of 123) with videos related to
Page
of 13
Sort By:
European Archives of Psychiatry and Clinical Neuroscience
|
January 1, 1995
Cardiovascular effects of fluvoxamine and maprotiline in depressed patients
W Hewer, W Rost, W F Gattaz
Pharmacopsychiatry
|
March 1, 1994
Latency increase of auditory-evoked potential component N1 predicts poor neuroleptic response in schizophrenic patients
G Adler, U Markert, W F Gattaz
Psychiatry Research
|
February 1, 1984
Melatonin immunoreactivity in cerebrospinal fluid of schizophrenic patients and healthy controls
H Beckmann, L Wetterberg, W F Gattaz
The British Journal of Psychiatry : the Journal of Mental Science
|
October 1, 1980
HL-A-antigens, schizophrenia and brain atrophy
W F Gattaz, S Kasper, H Beckmann
Acta Psychiatrica Scandinavica
|
November 1, 1982
CSF monoamine metabolites in schizophrenic patients
W F Gattaz, P Waldmeier, H Beckmann
The British Journal of Psychiatry : the Journal of Mental Science
|
March 1, 1983
Low CSF concentrations of cyclic GMP in schizophrenia
W F Gattaz, H Cramer, H Beckmann
European Archives of Psychiatry and Clinical Neuroscience
|
January 1, 1992
The deleterious effect of ocular artefacts on the quantitative EEG, and a remedy
T Gasser, P Ziegler, W F Gattaz
Psychopathology
|
January 1, 1990
Münchhausen syndrome: psychopathology and management
W F Gattaz, H Dressing, W Hewer
Journal of Neural Transmission. General Section
|
January 1, 1994
Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats
W F Gattaz, B Schummer, S Behrens
Biological Psychiatry
|
April 1, 1985
Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls
W F Gattaz, T Gasser, H Beckmann
Page
of 13
Search research articles
Search
Showing results (31-40 of 123) with videos related to
Sort By:
Page
of 13
European Archives of Psychiatry and Clinical Neuroscience
|
January 1, 1995
Cardiovascular effects of fluvoxamine and maprotiline in depressed patients
W Hewer, W Rost, W F Gattaz
Pharmacopsychiatry
|
March 1, 1994
Latency increase of auditory-evoked potential component N1 predicts poor neuroleptic response in schizophrenic patients
G Adler, U Markert, W F Gattaz
Psychiatry Research
|
February 1, 1984
Melatonin immunoreactivity in cerebrospinal fluid of schizophrenic patients and healthy controls
H Beckmann, L Wetterberg, W F Gattaz
The British Journal of Psychiatry : the Journal of Mental Science
|
October 1, 1980
HL-A-antigens, schizophrenia and brain atrophy
W F Gattaz, S Kasper, H Beckmann
Acta Psychiatrica Scandinavica
|
November 1, 1982
CSF monoamine metabolites in schizophrenic patients
W F Gattaz, P Waldmeier, H Beckmann
The British Journal of Psychiatry : the Journal of Mental Science
|
March 1, 1983
Low CSF concentrations of cyclic GMP in schizophrenia
W F Gattaz, H Cramer, H Beckmann
European Archives of Psychiatry and Clinical Neuroscience
|
January 1, 1992
The deleterious effect of ocular artefacts on the quantitative EEG, and a remedy
T Gasser, P Ziegler, W F Gattaz
Psychopathology
|
January 1, 1990
Münchhausen syndrome: psychopathology and management
W F Gattaz, H Dressing, W Hewer
Journal of Neural Transmission. General Section
|
January 1, 1994
Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats
W F Gattaz, B Schummer, S Behrens
Biological Psychiatry
|
April 1, 1985
Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls
W F Gattaz, T Gasser, H Beckmann
Page
of 13